Reports Hub

Consultation by: Department of Health and Social Care

Healthwatch Birmingham and Solihull responded to the government’s call for evidence on regulating AI in healthcare, emphasising the importance of transparency, clear consent processes and strong patient voice. We highlighted the need for patient feedback to form part of long term monitoring of AI systems, and for clear accountability when decisions are influenced by AI. We also called for national consistency in how AI use is communicated to patients, and stressed the importance of human safeguards, especially in higher risk areas such as mental health.

Consultation by: Department of Health and Social Care

Healthwatch Birmingham and Solihull responded to the government’s consultation on proposed changes to how NICE sets cost‑effectiveness thresholds. We raised concerns about risks to NICE’s independence and the potential for ministerial priorities to override clinical evidence, which could disadvantage people with rare or complex conditions. We warned that removing consultation requirements may limit patient voice and transparency. We also highlighted the risk of widening health inequalities if changes to thresholds are not fully assessed for their impact on public health.